Using alli for weight loss? What the new FDA kidney warning means

If you use or are considering alli for weight loss, the new FDA warning is a reason to slow down and read the label, not a panic signal. On June 10, 2026, the FDA approved a label change for the over-the-counter drug alli (orlistat 60 mg) warning about rare kidney injury and kidney stones. The product was not recalled.

For most readers, the practical question is whether this means they should stop taking it right away. Usually, no. The bigger message is to check your kidney history, review your other medicines, and know which symptoms mean you should stop using the product and get medical advice. FDA says alli remains the only FDA-approved over-the-counter weight-loss aid.

What changed

The updated Drug Facts label now tells people to ask a doctor before using alli if they have ever had kidney disease or kidney stones. It also says to stop using the product and ask a doctor if symptoms of kidney injury or kidney stones appear.

The label still limits alli to one capsule with each meal that contains fat, up to three capsules a day. It also advises taking a daily multivitamin, usually at bedtime, because orlistat can reduce absorption of some vitamins.

Why FDA acted

FDA said it reviewed postmarketing safety reports and medical literature from alli’s approval on February 9, 2007, through December 31, 2023. The agency identified 12 kidney-related cases linked to alli use: 8 reports of acute kidney injury, 2 reports of acute kidney injury with oxalate nephropathy, and 2 reports involving high urinary oxalate with calcium oxalate kidney stones. Eight patients were hospitalized, and 5 required dialysis.

That sounds serious, and it is. But FDA also described the event as rare and noted important limits. Side effects are often underreported. Some reports were missing key details. And some patients had other possible reasons for kidney problems, including obesity, diabetes, high blood pressure, prior kidney disease, or a history of kidney stones. In other words, the warning matters, but it does not prove that alli causes kidney injury in every case or show exactly how often it happens.

Why this may happen

Medical reports describe a plausible explanation involving oxalate, a substance the body also gets from some foods. Orlistat reduces fat absorption. In some people, that may increase oxalate absorption in the gut, which can contribute to calcium oxalate crystals in the urinary tract or kidney tissue. Published reports support that this complication is biologically possible, but the evidence mainly comes from case reports and reviews, not large trials designed to measure the real-world rate.

Symptoms that matter now

The updated warning tells consumers to watch for possible signs of kidney injury or kidney stones while using alli. Stop using the product and contact a clinician promptly if you develop:

back or groin pain
painful urination
blood in the urine
swelling in the feet or legs
urinating less often than normal

If symptoms are severe, if you are passing very little urine, or if you feel very unwell, seek urgent medical care.

Who should check with a clinician before using alli

The clearest group to check first is people with a history of kidney disease or kidney stones. The label and MedlinePlus also point to other important cautions. Cyclosporine is a do-not-use combination, and other medicines may need clinician or pharmacist review first, including blood thinners such as warfarin, amiodarone, diabetes medicines, thyroid medicine, seizure medicines, and some HIV medicines. MedlinePlus also notes that timing matters with medicines such as cyclosporine and levothyroxine because orlistat can affect absorption.

If you have had an organ transplant, have problems absorbing food, or have a complicated medication list, this is not a drug to start casually without checking first.

What remains uncertain

The safest way to understand this update is as a rare-but-serious warning. FDA’s review shows a signal strong enough to change the label, but not enough to tell consumers that kidney complications are common. The true number of cases may be higher than reported, but many reports also lacked enough information to rule out other causes. That means readers should take the warning seriously without assuming it means alli is suddenly unsafe for everyone.

Bottom line

The new FDA warning is a reason to use alli more carefully, not a reason for every consumer to panic. Read the current Drug Facts label, stay within package directions, and know the red-flag symptoms. If you have a history of kidney disease, kidney stones, or medication interactions, check with a clinician or pharmacist before using it.

Sources

Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.

This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.